Grow Your Wealth
with Mutual Funds
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw
Equity
Large Cap
Very High Risk
Latest AUM
₹ 167.2 Cr.
NAV as on 24 jul, 2026
₹ 23.41
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw
Inception Date
26 Oct 2020
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
99.78%
Debt
0.17%
Cash
0.05%
Portfolio Updated on: 11 Jul, 2026
Sector Allocations
Equity
Healthcare
Portfolio Updated on: 24 jul, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.50% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.50% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.25% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.73% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.98% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.16% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.16% |
Debt & Credit Risk Analysis
| Alpha | 1.38% |
| Beta | 0.68% |
| Sharpe Ratio | 1.07% |
| Standard Deviation | 12.57% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 14.14% | NA | 6.12% |
| 6 Months | 15.03% | NA | 12.92% |
| 9 Months | 14.89% | NA | 4.47% |
| 1 Year | 17.10% | 17.10% | 6.04% |
| 2 Years | 26.25% | 12.36% | 24.93% |
| 3 Years | 70.52% | 19.47% | 25.71% |
| 5 Years | 82.54% | 12.79% | 19.91% |
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw is one Equity mutual fund offered by Edelweiss Mutual Fund. Launched on 26 Oct 2020, the fund aims Long Term Capital appreciation. Passive investment in equity and equity related securities replicating the composition of MSCI India Domestic & World Healthcare 45 Index, subject to tracking error. It manages assets worth ₹167.2 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.06%.
Bhavesh Jain has experience Prior to joining Edelweiss Mutual Fund he was previously associated with Edelweiss Securities Limited as SGX Nifty Arbitrage Trader.
Amit Vora has experience Antique Stock Broking Ltd, D.E. Shaw India Securities Pvt. Ltd, Derivium Tradition Securities (India) Pvt Ltd, Tower Capital & Securities Pvt Ltd and B&K Securities
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
| SBI Healthcare Opportunities Fund-idcw | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-growth | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
| DSP Healthcare Fund Direct-idcw | 2,891.8 | +1.99% | +14.55% | +16.80% | +8.22% | +21.75% | +15.57% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from Edelweiss Mutual Fund
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth | 7,898.2 | +0.77% | +9.68% | +14.42% | +5.29% | +18.85% | +12.13% |
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +0.84% | +9.91% | +14.91% | +6.23% | +19.92% | +13.15% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +0.84% | +9.91% | +14.91% | +6.23% | +19.92% | +13.15% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +0.77% | +9.68% | +14.42% | +5.29% | +18.85% | +12.13% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +0.33% | +11.22% | +14.67% | +5.40% | +23.49% | +15.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +0.33% | +11.22% | +14.67% | +5.40% | +23.49% | +15.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +0.41% | +11.45% | +15.17% | +6.29% | +24.54% | +16.25% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +2.56% | +16.83% | +23.87% | +13.52% | +23.77% | +17.21% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +2.48% | +16.55% | +23.25% | +12.39% | +22.49% | +15.98% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹574.88 | +23.77% | +17.21% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹399.41 | +23.77% | +17.21% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹46.62 | +24.54% | +16.25% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.15 | +24.54% | +16.25% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹496.93 | +22.49% | +15.98% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹313.04 | +22.49% | +15.98% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-growth | ₹48.48 | +21.75% | +15.57% | — |
| Dsp Healthcare Fund Direct-idcw | ₹28.04 | +21.75% | +15.57% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 24 Jul 2026 | ₹23.41 |
| 23 Jul 2026 | ₹23.41 |
| 22 Jul 2026 | ₹23.34 |
| 21 Jul 2026 | ₹23.54 |
| 20 Jul 2026 | ₹23.47 |
| 17 Jul 2026 | ₹23.36 |
| 16 Jul 2026 | ₹23.55 |
| 15 Jul 2026 | ₹23.38 |
| 14 Jul 2026 | ₹23.28 |
| 13 Jul 2026 | ₹23.26 |
| 10 Jul 2026 | ₹23.26 |
| 09 Jul 2026 | ₹23.30 |
| 08 Jul 2026 | ₹23.15 |
| 07 Jul 2026 | ₹23.45 |
| 06 Jul 2026 | ₹23.46 |
| 02 Jul 2026 | ₹23.24 |
| 01 Jul 2026 | ₹22.88 |
| 30 Jun 2026 | ₹22.96 |
| 29 Jun 2026 | ₹22.99 |
| 25 Jun 2026 | ₹22.57 |
| 24 Jun 2026 | ₹22.47 |
| 23 Jun 2026 | ₹22.36 |
| 22 Jun 2026 | ₹22.15 |
| 18 Jun 2026 | ₹21.77 |
| 17 Jun 2026 | ₹21.69 |
| 16 Jun 2026 | ₹21.81 |
| 12 Jun 2026 | ₹22.06 |
| 11 Jun 2026 | ₹22.07 |
| 10 Jun 2026 | ₹21.90 |
| 09 Jun 2026 | ₹22.05 |
Portfolio Updated on: 25 Jul, 2026
Fund Growth & Size Analysis
+₹167.2 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw Returns Comparison
Compare Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
Edelweiss Msci India D....
No funds found for your search.
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw FAQ'S
- Sharpe Ratio: 1.07%
- Standard Deviation: 12.57%
- Beta: 0.68%
- Alpha: 1.38%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw stand at approximately ₹ 167.2 crore.
The Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw has delivered the following short-term performance:
- 3 Months Return: 14.14%
- 6 Months Return: 15.03%
The historical growth of the Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw is reflected through its CAGR returns:
- 3 Year CAGR: 19.47%
- 5 Year CAGR: 12.79%
- Return Since Launch: 15.96%
The portfolio of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw is distributed across different asset classes as follows:
- Equity: 99.78%
- Debt Instruments: 0.17%
- Other Assets: 0.05%
The Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw is managed by Amit Vora, representing Edelweiss Mutual Fund.
The Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw include:
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.50% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.50% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.25% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.73% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.98% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.16% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.16% of the portfolio
Major sector exposures in Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw are:
- Healthcare – accounts for 1,086.73% of the portfolio
